Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1979 1
1981 5
1982 6
1983 4
1984 5
1985 10
1986 6
1987 9
1988 12
1989 14
1990 20
1991 11
1992 17
1993 11
1994 11
1995 24
1996 10
1997 13
1998 16
1999 18
2000 22
2001 23
2002 35
2003 47
2004 56
2005 51
2006 50
2007 60
2008 74
2009 102
2010 131
2011 165
2012 181
2013 193
2014 234
2015 253
2016 294
2017 341
2018 379
2019 432
2020 492
2021 563
2022 686
2023 749
2024 771
2025 377

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,243 results

Results by year

Filters applied: . Clear all
Page 1
Emerging roles of Aurora-A kinase in cancer therapy resistance.
Zheng D, Li J, Yan H, Zhang G, Li W, Chu E, Wei N. Zheng D, et al. Acta Pharm Sin B. 2023 Jul;13(7):2826-2843. doi: 10.1016/j.apsb.2023.03.013. Epub 2023 Mar 15. Acta Pharm Sin B. 2023. PMID: 37521867 Free PMC article. Review.
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy.
Zhang YP, Guo ZQ, Cai XT, Rong ZX, Fang Y, Chen JQ, Zhuang KM, Ruan MJ, Ma SC, Lin LY, Han DD, Li YS, Wang YY, Wang J, Cao CH, Tang XR, Xie QK, Chen Y, Lin Y, Tan JL, Yu ZH, Wu ZN, Wei W, Zheng DY, Zeng YJ, Ruan YC, Xu ZP, Gu JZ, Xiao LS, Liu L, Guan J, Bai X, Wu DH, Dong ZY. Zhang YP, et al. Among authors: zheng dy. Cancer Cell. 2025 May 12;43(5):856-874.e9. doi: 10.1016/j.ccell.2025.02.024. Epub 2025 Mar 13. Cancer Cell. 2025. PMID: 40086438
A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression.
Liu Y, John P, Nishitani K, Cui J, Nishimura CD, Christin JR, Couturier N, Ren X, Wei Y, Pulanco MC, Galbo PM Jr, Zhang X, Fu W, Cui W, Bartholdy BA, Zheng D, Lauvau G, Fineberg SA, Oktay MH, Zang X, Guo W. Liu Y, et al. Among authors: zheng d. Dev Cell. 2023 Dec 4;58(23):2700-2717.e12. doi: 10.1016/j.devcel.2023.10.010. Epub 2023 Nov 13. Dev Cell. 2023. PMID: 37963469 Free PMC article.
iMeta Conference 2024: Building an innovative scientific research ecosystem for microbiome and One Health.
Wang Y, Hou H, Luo H, Xun J, Ma C, Yang H, Bai D, Yousuf S, Lyu H, Zhang T, Wan X, Yao X, Ma T, Zhou Y, Zhu Z, Zeng M, An S, Bai Q, Bai Y, Cao G, Cao T, Cao Y, Chang C, Chang L, Chen B, Chen D, Chen D, Chen H, Chen J, Chen J, Chen WH, Chen X, Chen Y, Chen Z, Cheng C, Cheng Q, Dai XJ, Deng C, Deng F, Deng J, Dong CS, Dong L, Duan L, Duan Y, Fan Q, Fang C, Fang T, Fang W, Fang Z, Fu M, Fu M, Gao C, Gao H, Gao W, Gao X, Gao YZ, Geng Y, Gong W, Gu S, Gu X, Gu Z, Guo JW, Guo J, Guo Q, Guo X, Guo X, Han D, Han Z, Hao Y, He J, He J, He J, He R, Hou G, Hu B, Hu H, Hu Y, Hu Y, Hu Y, Huang G, Huang H, Huang J, Huang S, Jia B, Jian X, Jiang C, Jiang K, Jiang L, Jiang S, Jiao JY, Jin H, Jin J, Kong S, Lai X, Leng Y, Li B, Li B, Li F, Li H, Li H, Li J, Li K, Li L, Li L, Li M, Li P, Li W, Li W, Li X, Xuemeng L, Li Y, Li Y, Li Z, Liang L, Liang R, Liang Z, Liu Q, Liu D, Liu H, Liu J, Liu L, Liu L, Liu M, Liu R, Liu S, Liu T, Liu W, Liu W, Liu X, Liu Y, Liu Y, Liu Y, Liu Y, Liu Z, Liu Z, Liu Z, Long C, Long Y, Lu C, Lu C, Lu C, Lu Q, Luan Y, Luo P, Luo S, Ma N, Ma XY, Ma Y, Mao W, Meng Y, Ni Y, Ni Y, Ning K, Niu D, Peng K, Peng Z, Qian X, Qiu Z, Qu H, Qu Z, Ren Y, Ren Z, Shen Y, Shi L, Shi L, Shi… See abstract for full author list ➔ Wang Y, et al. Among authors: zheng d. Imeta. 2024 Dec 15;3(6):e251. doi: 10.1002/imt2.251. eCollection 2024 Dec. Imeta. 2024. PMID: 39742310 Free PMC article.
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, Fan X, Sun W, Han Y, Lv Q, Liu R, Yang D, Shi Z, Zheng D, Deng X, Wan Y, Wang Z, Geng Y, Chen X, Zhou Z, Liao G, Jin P, Liu Y, Liu X, Zhang M, Zhou F, Shi H, Zhang Y, Guo F, Yin C, Niu G, Zhang M, Cai X, Zhu Q, Chen Z, Liang Y, Li B, Lin M, Wang W, Xu H, Fu X, Liu W, Tian X, Gong Z, Shi H, Wang C, Lv P, Tao Z, Zhu L, Yang S, Hu W, Jiang P, Liebeskind DS, Pereira VM, Leung T, Yan B, Davis S, Xu G, Nogueira RG; BEST Trial Investigators. Liu X, et al. Among authors: zheng d. Lancet Neurol. 2020 Feb;19(2):115-122. doi: 10.1016/S1474-4422(19)30395-3. Epub 2019 Dec 9. Lancet Neurol. 2020. PMID: 31831388 Clinical Trial.
6,243 results